HIGHLIGHTS
- who: Yaqun Jiang et al. from the Department of Nuclear Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China have published the article: Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin v3 for Pancreatic Cancer Imaging, in the Journal: Pharmaceutics 2022, 1791 of 14/07/2022
- what: The authors developed a 68 Ga-yG5-RGD both and integrin αv β3 and evaluated its feasibility and utility in PET imaging of pancreatic cancer. The aim of this study was to develop a dual receptor targeting peptide heterodimer . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.